AstraZeneca’s chief executive, Paul Soriot, told reporters the company's decision to build a $400 million API plant in Ireland versus the U.K. was based on “discouraging” tax rates. (AstraZeneca) ...
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...
Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this author to personalize your feed and get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results